---
title: "Neuland Laboratories Ltd (NEULANDLAB) — Share Price, Financials & Analysis"
symbol: "NEULANDLAB"
company: "Neuland Laboratories Ltd"
canonical: "https://tapetide.com/stocks/NEULANDLAB"
isin: "INE794A01010"
nse_symbol: "NEULANDLAB"
bse_code: "524558"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 30188.73
generated_at: "2026-09-13T18:19:23.239Z"
---

# Neuland Laboratories Ltd (NEULANDLAB)

Canonical page: https://tapetide.com/stocks/NEULANDLAB

## Company

- **NSE Symbol:** NEULANDLAB
- **BSE Code:** 524558
- **ISIN:** INE794A01010
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2008-10-13
- **CEO:** Dr. Davuluri Rama Mohan Rao
- **Employees:** 1794
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** neulandlabs.com

## About

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.[1]

## Latest Price

- **Price:** ₹23535
- **Change:** -265 (-1.11%)
- **Open:** ₹23780
- **Day High:** ₹23895
- **Day Low:** ₹23225
- **Previous Close:** ₹23800
- **Volume:** 43901
- **As Of:** 2026-09-11T10:20:08+00:00

## Key Fundamentals

Observed at 2026-09-11T04:35:46.631349Z.

- **Market Cap:** ₹30188.73 Cr
- **Classification:** Smallcap
- **P/E (reported):** 61.3
- **P/E (TTM):** 60.66
- **EPS (TTM):** ₹387.97
- **EPS (reported):** ₹249.83
- **Book Value:** ₹1460.31
- **Price to Book:** 16.3
- **Dividend Yield:** 0.14%
- **ROE:** 19.42%
- **ROCE:** 23.11%
- **Debt to Equity:** 0.16
- **Revenue (yearly):** ₹2053.2 Cr
- **Net Income:** ₹364 Cr
- **EBITDA:** ₹604.7 Cr
- **52-Week High:** ₹24225
- **52-Week Low:** ₹11500
- **RSI (14):** 62.11

## Tapetide Score

- **Score:** 57 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 77.8 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 75.7 | 9% |
| growth | 98.9 | 9% |
| momentum | 90.69 | 12% |
| ownership | 52.84 | 24% |
| quality | 44.24 | 22% |
| valuation | 32.86 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter
- Company has delivered good profit growth of 38.5% CAGR over last 5 years

### Weaknesses

- Stock is trading at 16.1 times its book value
- Promoter holding has decreased over last 3 years: -3.41%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 9.22% | 32.74% | 474.07% |
| ebitda margin growth | -27.64% | 28.27% | -2.61% | 94.01% |
| net income growth | -30.56% | 39.95% | 30% | 39% |
| revenue growth | -17.57% | 37.13% | 19% | 17% |
| roce | -30.5% | 11.7% | -21.85% | 20.56% |
| roe | -30.56% | 13.83% | 19.96% | 155.86% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 418 | 393 | 385 | 440 | 311 | 398 | 328 | 293 | 514 | 440 | 776 | 642 |
| Expenses | 280 | 272 | 278 | 316 | 249 | 311 | 277 | 258 | 359 | 363 | 469 | 419 |
| Operating Profit | 137 | 121 | 107 | 123 | 62 | 87 | 51 | 34 | 156 | 77 | 307 | 223 |
| OPM % | 33 | 31 | 28 | 28 | 20 | 22 | 16 | 12 | 30 | 18 | 40 | 35 |
| Other Income | 3 | 2 | 5 | 25 | 4 | 60 | 7 | 8 | 2 | 8 | 12 | 8 |
| Interest | 4 | 4 | 4 | 3 | 1 | 2 | 2 | 5 | 5 | 7 | 7 | 7 |
| Depreciation | 15 | 15 | 16 | 16 | 16 | 16 | 17 | 20 | 23 | 24 | 25 | 27 |
| Profit before tax | 122 | 104 | 92 | 130 | 49 | 128 | 39 | 18 | 129 | 54 | 287 | 198 |
| Tax % | 27 | 22 | 27 | 25 | 34 | 20 | 29 | 21 | 25 | 26 | 26 | 25 |
| Net Profit | 89 | 81 | 68 | 98 | 33 | 102 | 28 | 14 | 97 | 41 | 213 | 148 |
| EPS in Rs | 69.56 | 63.44 | 52.66 | 76.28 | 25.6 | 79.18 | 21.68 | 10.83 | 75.49 | 31.62 | 165.76 | 115.1 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 527 | 667 | 763 | 937 | 951 | 1191 | 1559 | 1477 | 2023 | 2372 |
| Expenses | 477 | 608 | 661 | 790 | 807 | 918 | 1096 | 1146 | 1443 | 1609 |
| Operating Profit | 51 | 58 | 102 | 147 | 144 | 273 | 463 | 331 | 580 | 763 |
| OPM % | 10 | 9 | 13 | 16 | 15 | 23 | 30 | 22 | 29 | 32 |
| Other Income | 4 | 3 | 4 | 16 | 0 | 9 | 12 | 90 | 25 | 31 |
| Interest | 19 | 16 | 22 | 18 | 14 | 13 | 14 | 8 | 24 | 26 |
| Depreciation | 22 | 26 | 31 | 40 | 49 | 53 | 60 | 66 | 92 | 98 |
| Profit before tax | 14 | 20 | 53 | 105 | 82 | 216 | 401 | 346 | 489 | 669 |
| Tax % | 13 | 19 | 69 | 23 | 22 | 24 | 25 | 25 | 26 | — |
| Net Profit | 12 | 16 | 16 | 81 | 64 | 164 | 300 | 260 | 364 | 498 |
| EPS in Rs | 13.57 | 12.81 | 12.63 | 62.85 | 49.74 | 127.45 | 233.89 | 202.74 | 283.71 | 387.97 |
| Dividend Payout % | 0 | 0 | 16 | 8 | 10 | 8 | 6 | 6 | 12 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 9 | 9 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 537 | 549 | 686 | 697 | 774 | 828 | 981 | 1270 | 1512 | 1862 |
| Borrowings | 192 | 319 | 231 | 264 | 182 | 241 | 128 | 95 | 157 | 301 |
| Other Liabilities | 148 | 194 | 200 | 257 | 356 | 302 | 457 | 454 | 498 | 754 |
| Total Liabilities | 886 | 1071 | 1130 | 1231 | 1325 | 1383 | 1580 | 1833 | 2180 | 2930 |
| Fixed Assets | 466 | 475 | 542 | 653 | 716 | 767 | 758 | 824 | 955 | 1177 |
| CWIP | 20 | 126 | 104 | 24 | 17 | 20 | 41 | 46 | 48 | 211 |
| Investments | 8 | 8 | 8 | 8 | 7 | 4 | 1 | 1 | 109 | 2 |
| Other Assets | 393 | 463 | 476 | 547 | 585 | 592 | 781 | 962 | 1068 | 1541 |
| Total Assets | 886 | 1071 | 1130 | 1231 | 1325 | 1383 | 1580 | 1833 | 2180 | 2930 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 39 | 11 | 70 | 57 | 189 | 60 | 237 | 261 | 317 | 347 |
| Cash from Investing Activity | -42 | -116 | -77 | -49 | -84 | -95 | -61 | -150 | -298 | -423 |
| Cash from Financing Activity | 0 | 105 | 12 | -5 | -114 | 38 | -136 | -69 | 25 | 21 |
| Net Cash Flow | -4 | 0 | 5 | 3 | -9 | 3 | 40 | 42 | 44 | -55 |
| Free Cash Flow | -2 | -121 | 7 | 9 | 84 | -37 | 173 | 119 | 112 | -50 |
| CFO/OP | 52 | 28 | 128 | 61 | 132 | 56 | 103 | 81 | 119 | 78 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 114 | 134 | 90 | 91 | 85 | 90 | 111 | 87 | 78 | 98 |
| Inventory Days | 186 | 266 | 191 | 209 | 205 | 227 | 211 | 220 | 238 | 245 |
| Days Payable | 118 | 189 | 118 | 110 | 126 | 100 | 129 | 121 | 156 | 129 |
| Cash Conversion Cycle | 182 | 211 | 162 | 190 | 164 | 216 | 193 | 187 | 160 | 214 |
| Working Capital Days | 44 | 38 | 138 | 137 | 60 | 74 | 81 | 88 | 76 | 75 |
| ROCE % | 16 | 4 | 4 | 8 | 11 | 10 | 21 | 33 | 19 | 26 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 35.97% | 32.8% | 32.74% | 32.72% | 32.64% | 32.68% | 32.68% | 32.68% | 32.64% | 32.63% | 32.63% | 32.62% |
| FIIs | 21.57% | 22.69% | 24.44% | 25.72% | 26.46% | 23.86% | 22.11% | 21.69% | 20.6% | 20.9% | 20.46% | 21.08% |
| DIIs | 6.99% | 6.03% | 6.54% | 6.39% | 6.38% | 9.08% | 10.97% | 11.57% | 13.54% | 14.71% | 15.84% | 16.51% |
| Government | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0% | 0% | 0% |
| Public | 27.86% | 29.51% | 27.97% | 27.05% | 26.5% | 26.05% | 25.86% | 25.55% | 24.72% | 24.31% | 23.84% | 22.88% |
| Others | 7.21% | 8.57% | 7.91% | 7.71% | 7.61% | 7.93% | 7.99% | 8.12% | 8.09% | 7.45% | 7.22% | 6.91% |
| No. of Shareholders | 26824 | 27723 | 28616 | 29077 | 34567 | 39315 | 39333 | 42419 | 44393 | 46187 | 46304 | 44340 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 6 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 23194 | Buy |
| EMA (10) | 23315.7 | Buy |
| SMA (20) | 23261.45 | Buy |
| EMA (20) | 22960.06 | Buy |
| SMA (50) | 21238.86 | Buy |
| EMA (50) | 21476.36 | Buy |
| SMA (100) | 19048.37 | Buy |
| EMA (100) | 19606.33 | Buy |
| SMA (200) | 16601.33 | Buy |
| EMA (200) | 17557.73 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 59.07 | Neutral |
| MACD (12,26,9) | 588.92 | Sell |
| Stochastic (14,3,3) | 60.5 | Neutral |
| ADX (14) | 40.75 | Buy |
| Williams %R (14) | -38.12 | Neutral |
| ATR (14) | 724.45 | High Volatility |
| ROC (12) | -0.04 | Sell |
| Stoch RSI (14) | 28.79 | Neutral |
| UO (7,14,28) | 50.83 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 4 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 4 analyst ratings, observed at 2026-09-11T04:35:47.758552+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3bf93ac-8a17-4dab-bd0e-c7209e9354a6.pdf) |
| 2026-09-07 | [Disclosure Under Regulation 30 Of SEBI Listing Regulations](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=216fc9d0-6e69-4b8b-a964-8a10a7b25e29.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64b815b7-e59f-4a99-86f2-02e4d2c750c3.pdf) |
| 2026-08-23 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7751ed29-aff3-4143-8ed5-4f843e3f82a7.pdf) |
| 2026-08-17 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E9CB3BE8_599E_41CB_813C_1B48DFD5ECD3_140311.pdf) |
| 2026-08-14 | [Intimation Regarding Completion Of US FDA Inspection](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=808535d5-c8ac-4ae2-a708-98363b881316.pdf) |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adc6a7a8-7303-45c5-8e3e-a0a337794108.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6040ae02-229b-497b-bc7b-53a4bd59d629.pdf) |
| 2026-08-05 | [Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e59d541a-9b22-4200-bca3-d890438f8252.pdf) |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b9a42ec-322f-4a12-a32b-0895896f0654.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2741a4de-4965-4ee5-bea1-d9e45ab8d7c0.pdf) |
| 2026-05-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06f04201-decf-48dd-9d57-0f661e796dfc.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b41d3dda-701e-433e-bc58-3227c0bf76fa.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9431d47d-166e-4f67-90b3-7e7a20bdaf2e.pdf) |
| 2025-08-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10f22588-7577-4d88-9621-acbbc292eb59.pdf) |
| 2025-02-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bb9ddcf-7706-48f6-bb1e-410ac37ceafe.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c46c264-3cd1-4c5f-b273-3db4d9b5ecd5.pdf) |
| 2024-08-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bc0207a-de4c-41f7-a720-c936fc796a2e.pdf) |
| 2024-05-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9de4118-f984-47bd-923d-5e1df7cdd67b.pdf) |
| 2024-02-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a981ee48-44b2-49e6-baa2-ae0dc1fce75a.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-05 | [Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b685a06b-d8a2-4a14-aa5f-7e7a037cc52b.pdf) |
| 2026-05-12 | [Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faaed58b-e4f9-47a3-8e1f-7614c5905373.pdf) |
| 2026-02-09 | [Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5ea88c1-f9c1-40b9-ab7b-e5dc38523e8d.pdf) |
| 2025-11-07 | [Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a60f15e2-578b-4a0c-bba3-be249a9fd4e0.pdf) |
| 2025-07-31 | [Unaudited Financial Results For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dcfffb6-a551-48fb-9a05-f75134edaceb.pdf) |
| 2025-05-15 | [Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2024-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c60742c1-4eac-4e6d-8c25-7f65223a9e75.pdf) |
| 2025-02-10 | [Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ac4a9d3-88ee-4993-b254-b80af101a895.pdf) |
| 2024-11-06 | [Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a56b6d4-c047-4f29-a83d-10c22d17f36e.pdf) |
| 2024-08-01 | [Unaudited Financial Results For Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9ef5edf-3e3c-4d9a-b7e8-10755cfbb691.pdf) |
| 2024-05-10 | [Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2023-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03d7bde5-dd2f-4817-b0d3-0dfaba3f9971.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40129e92-e9b5-4fd8-8f9a-49885d22f81a.pdf) |
| 2026-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db0a56d6-195c-4f1a-ad15-587ec87b25f4.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f789c6ae-40ed-49ab-8264-dc74f0976e23.pdf) |
| 2025-11-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f4a2a49-c8a4-4d3b-92d1-0149798a4093.pdf) |
| 2025-07-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f91a6323-fca2-455a-809c-f3f2e7095ed2.pdf) |
| 2025-05-15 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12bfa8ba-de7c-435e-9104-c0ef26b66c6a.pdf) |
| 2025-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4b2a46e-abff-4f5d-95ba-6cf771b7f227.pdf) |
| 2024-11-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf538063-b638-4707-a799-347b298c3679.pdf) |
| 2024-08-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e355da-4450-4458-938a-91eccff280d1.pdf) |
| 2024-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44a45297-a7b7-4b81-af25-f5fa2069589a.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d89172e6-1459-4374-aea2-e411e4c69433.pdf) |
| 2026-05-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbb98d42-884d-4313-b526-bcd8ffbe7183.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=990e5098-04e9-43e1-87c7-47605c516fdc.pdf) |
| 2025-11-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3feb2c9d-9e98-4eca-ac45-7f179bc6069a.pdf) |
| 2025-07-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4d84315-7d3c-4703-b959-af8eb8cfde44.pdf) |
| 2025-05-15 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96516106-9f51-4c7e-943d-a9e39f13dd7c.pdf) |
| 2024-11-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe3cad1d-c952-40d1-93fb-32e74bf9da4c.pdf) |
| 2024-08-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46138374-83bf-4147-83f6-3185b3a6db41.pdf) |
| 2024-05-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=608ee996-b308-4f00-8215-0cb676d1091e.pdf) |
| 2024-02-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfddf7a1-a807-485e-ae9e-24a3042f7304.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9431d47d-166e-4f67-90b3-7e7a20bdaf2e.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7c46c264-3cd1-4c5f-b273-3db4d9b5ecd5.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8ba9dff-dea1-4082-aea3-af81114f6829.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8ba9dff-dea1-4082-aea3-af81114f6829.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bcd36f7e-781f-4afa-a640-b0e8622a0b37.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/efa2ad6f-15ab-4dc1-93db-71f5cc7dfd9e.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/06f04201-decf-48dd-9d57-0f661e796dfc.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/06f04201-decf-48dd-9d57-0f661e796dfc.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/db0a56d6-195c-4f1a-ad15-587ec87b25f4.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/db0a56d6-195c-4f1a-ad15-587ec87b25f4.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7h - Board to meet on May 12, 2026 for FY26 audited results and possible final dividend. | [Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026, And; To Recommend Final Dividend, If Any, For The Financial Year Ended March 31, 2026 7h - Board to meet on May 12, 2026 for FY26 audited results and possible final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/14adbcc7-db93-4fdc-b412-73c774b03aa7.pdf) |
| 3 Mar - Dr Christopher M Cimarusti (DIN 02872948), Non-Executive Director, died Feb 28, 2026; on board since 2009. | [Announcement under Regulation 30 (LODR)-Demise 3 Mar - Dr Christopher M Cimarusti (DIN 02872948), Non-Executive Director, died Feb 28, 2026; on board since 2009.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ed1986bf-7998-4961-a194-ec8c41334c93.pdf) |
| 3 Mar - About Schedule of Analyst / Institutional Investor Meeting between March 10 to 12, 2026 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 3 Mar - About Schedule of Analyst / Institutional Investor Meeting between March 10 to 12, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c9a40618-1003-41a4-8d43-16b89bd2f94f.pdf) |
| 27 Mar - Promoter D. Saharsh Rao pledged 96,000 shares (0.75%) to Aditya Birla Money on 25-03-2026. | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 27 Mar - Promoter D. Saharsh Rao pledged 96,000 shares (0.75%) to Aditya Birla Money on 25-03-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0DA444F9_8D10_4D43_BC9D_7E5A3817B603_171703.pdf) |
| 23 Mar - Trading window closed April 1, 2026 until 48 hours after Q4/FY2026 results; board meeting date to be intimated. | [Closure of Trading Window 23 Mar - Trading window closed April 1, 2026 until 48 hours after Q4/FY2026 results; board meeting date to be intimated.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af74a2f3-1229-4f2e-adaf-d58cac5b6975.pdf) |
| 21 Apr - Newspaper advertisement of Notice for transferring unclaimed dividend and underlying equity shares to IEPF | [Announcement under Regulation 30 (LODR)-Newspaper Publication 21 Apr - Newspaper advertisement of Notice for transferring unclaimed dividend and underlying equity shares to IEPF](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fa72394c-8fd0-4553-94d5-fde11555a2b7.pdf) |
| 20 Apr - Board to meet on May 12, 2026 for FY26 audited results and possible final dividend. | [Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026, And; To Recommend Final Dividend, If Any, For The Financial Year Ended March 31, 2026 20 Apr - Board to meet on May 12, 2026 for FY26 audited results and possible final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14adbcc7-db93-4fdc-b412-73c774b03aa7.pdf) |
| 2 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 2 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72efe45a-6f19-4e72-8053-a676f18059f9.pdf) |
| 13h - Newspaper advertisement of Notice for transferring unclaimed dividend and underlying equity shares to IEPF | [Announcement under Regulation 30 (LODR)-Newspaper Publication 13h - Newspaper advertisement of Notice for transferring unclaimed dividend and underlying equity shares to IEPF](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fa72394c-8fd0-4553-94d5-fde11555a2b7.pdf) |
| 13 Feb - Transcript of the Earnings Call conducted on February 9, 2026 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 13 Feb - Transcript of the Earnings Call conducted on February 9, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b41d3dda-701e-433e-bc58-3227c0bf76fa.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ca5eae3-6582-47e6-be21-05bfb4b7fbac.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4e8106f-3a3a-440a-9f62-5c0d15714985.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a330fda6-abd5-44fd-8860-a17ed8400e30.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29fe1a51-c936-4700-8a96-9219dce5d082.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:19:23.239Z.